Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...

Over the past decade, advances in cancer genetics and oncogenomic have profoundly reshaped our understanding of pediatric tumors. Unlike adult cancers, ...

A state-of-the-art high-throughput sequencing device (Next-Generation Sequencing, NGS) is now available at the Keylab Genomics & Bioinformatics of the University of Bayreuth for rapid and ...

-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

Wastewater — a sanitized name for human fecal matter and urine — tells the story, providing evidence even before the symptoms ...

The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Josh Lauer explores the trends shaping sequencing, the science behind SBX technology, and how AXELIOS 1 is designed to ...

The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of ...